Log in

Relevant bibliographies by topics / Cervical Cancer

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Cervical Cancer'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 January 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cervical Cancer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cervical Cancer"

1

S Kadam, Sachin, and Tejaswini Kadam. "Endometrial Cancer with Cervical Extension Masquerading as Cervical Cancer." Cancer Research and Cellular Therapeutics 6, no. 3 (May 16, 2022): 01–03. http://dx.doi.org/10.31579/2640-1053/118.

Full text

Abstract:

The incidence and prevalence of endometrial cancer is less as compared to cervical cancer. Worldwide, in 2018, near about 382000 new cases of endometrial cancer were diagnosed and around 90000 women were died from the disease

APA, Harvard, Vancouver, ISO, and other styles

2

Yang, Nan, Esther R. Nijhuis, Haukeline H. Volders, Jasper J. H. Eijsink, Ágnes Lendvai, Bo Zhang, Harry Hollema, Ed Schuuring, G. Bea A. Wisman, and Ate G. J. van der Zeea. "Gene Promoter Methylation Patterns throughout the Process of Cervical Carcinogenesis." Analytical Cellular Pathology 32, no. 1-2 (January 1, 2010): 131–43. http://dx.doi.org/10.1155/2010/306087.

Full text

Abstract:

Objectives: To determine methylation status of nine genes, previously described to be frequently methylated in cervical cancer, in squamous intraepithelial lesions (SIL).Methods: QMSP was performed in normal cervix, low-grade (L)SIL, high-grade (H)SIL, adenocarcinomas and squamous cell cervical cancers, and in corresponding cervical scrapings.Results: Only CCNA1 was never methylated in normal cervices and rarely in LSILs. All other genes showed methylation in normal cervices, with CALCA, SPARC and RAR-β2 at high levels. Methylation frequency of 6 genes (DAPK, APC, TFPI2, SPARC, CCNA1 and CADM1) increased with severity of the underlying cervical lesion. DAPK showed the highest increase in methylation frequency between LSIL and HSIL (10% vs. 40%, p < 0.05), while CCNA1 and TFPI2 were most prominently methylated in cervical cancers compared to HSILs (25% vs. 52%, p < 0.05, 30% vs. 58%, p < 0.05). CADM1 methylation in cervical cancers was related to depth of invasion (p < 0.05) and lymph vascular space involvement (p < 0.01), suggesting a role in invasive potential of cervical cancers. Methylation ratios in scrapings reflected methylation status of the underlying lesions (p < 0.05).Conclusion: Methylation of previously reported cervical cancer specific genes frequently occurs in normal epithelium. However, frequency of methylation increases during cervical carcinogenesis, with CCNA1 and DAPK as the best markers to distinguish normal/LSIL from HSIL/cancer lesions.

APA, Harvard, Vancouver, ISO, and other styles

3

AziziKia, Hani, Hamidreza Didar, Azin Teymourzadeh, Amin Nakhostin-Ansari, Pooya Jafari Doudaran, Bahareh Ferasatifar, Armin Hoveidaei, and Gholamreza Roshandel. "Uterine and Cervical Cancer in Iran: An epidemiologic analysis of the Iranian National Population-Based Cancer Registry." Archives of Iranian Medicine 26, no. 1 (January 1, 2023): 1–7. http://dx.doi.org/10.34172/aim.2023.01.

Full text

Abstract:

Background: Gynecologic cancers, including neoplasms of the cervix and uterine, are the fourth most common malignancies, causing 3.46% of deaths in women aged 15 to 59. Objectives: We aimed to report the Iranian National Population-based Cancer Registry (INPCR) results for Cervical and Uterine cancers in 2017. Methods: The total population of Iran in 2017 was 80881792. INPCR collected data on cervical and uterine cancer incidence from 31 provinces of Iran. In this project, we retrospectively examined all the country’s regions in terms of screening for the existence of these two cancers. The registry data bank in Iran was used. Results: Overall, 3481 new cervical and uterine cancer cases were registered in INPCR, including 842 cases of cervical cancer (with a crude rate of 1.04) and 2639 cases of uterine cancer (with a crude rate of 3.26). The average age-standardized incidence rate (ASR) was 0.99 for cervical cancer and 3.29 for uterine cancer. Out of 3481 new cervical and uterine cancer cases, 2887 were registered with pathological findings and 594 without pathological confirmation. In cervical cancers, the highest rate was related to squamous cell carcinoma, with 486 cases (57.72%). Conclusion: Our results showed that Iran is a low-risk area for the incidence of cervical and uterine cancers. In this study, the highest rate of cervical cancer was related to squamous cell carcinoma, confirming previous reports. However, this rate was lower than previous studies and suggested an increase in other types of cervical cancer in Iran.

APA, Harvard, Vancouver, ISO, and other styles

4

Isakova, Dilnoza, Zebiniso Inakova, Ranokhon Solieva, Matkarimov Bakhtiyorjon, Yorkinoy Farmankulova, and Dilfuzahon Mamarasulova. "Clinical Echocolpocsopy Features Of Cervical Cancer." American Journal of Medical Sciences and Pharmaceutical Research 02, no. 07 (July 31, 2020): 123–29. http://dx.doi.org/10.37547/tajmspr/volume02issue07-16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Der, EM, K. Adu-Bonsaffoh, Y. Tettey, RA Kwame-Aryee, JD Seffah, H. Alidu, and RK Gyasi. "Clinico-pathological characteristics of cervical cancer in Ghanaian women." Journal of Medical and Biomedical Sciences 3, no. 3 (January 13, 2015): 27–32. http://dx.doi.org/10.4314/jmbs.v3i3.5.

Full text

Abstract:

Cervical cancer is a major cause of cancer related mortality in the developing countries, although preventable. The aim of this study was to use a retrospective descriptive study to determine the prevalence and the clinico-pathological characteristics of cervical cancer among genital tract ma-lignancies. This study reviewed all histologically confirmed female genital tract malignancies for cervical cancers from January 2002 to December 2011. The clinico-pathological features of women with cervical cancer were analyzed using SPSS software (version 18). A total of 1011(70.8%) out of 1,427 female genital tract malignancies were cervical cancers. The average prevalence of cervical cancer was 71.0%. The mean age of women with cervical cancer was 57.8(SD=13.8) years. The youngest patient was 22 years. The commonest (76.9%) presentation was bleeding per vaginalm followed by fungating cervical masses (12.4%). Majority (88.9%) of the bleeding were unprovoked and in postmenopausal women (98.8%). The major types of cervical cancers were Squamous cell carcinoma (SCC) (90.1%) and adenocarcinoma (5.8%), both were common in the elderly. The com-mon histological subtypes of cervical cancers in the study were; keratinizing SCC (73.3%), non-keratinizing SCC (14.7%), endometroid adenocarcinoma (4.5%), adenosquamous carcinoma (2.6%) and basaloid SCC (1.4%). This study found high prevalence of cervical cancer among female geni-tal tract cancers in Accra Ghana. The women were relatively older and presented with advanced stage of the disease. SCC was the major histological type of cervical cancer.Keywords: Ghana, cervical cancer, postmenopausal, women, premalignant, genital tract

APA, Harvard, Vancouver, ISO, and other styles

6

Iram, Ayesha. "Cancer Screening Technology and Attitude of Women Towards Cervical Cancer." TEXILA INTERNATIONAL JOURNAL OF ACADEMIC RESEARCH 9, no. 3 (July 30, 2022): 145–67. http://dx.doi.org/10.21522/tijar.2014.09.03.art013.

Full text

Abstract:

Cervical cancer claims over a quarter of a million lives of women annually worldwide. It is believed to be the second most common cancer among women worldwide. Screening is used to detect precancerous changes or early cancers before signs or symptoms of cancer occur. The first case of cervical cancer was founded in the 1970s by Harald Zur Hausen. It is believed to be the second most common cancer among women worldwide. Females becoming sexually active in early age with multiple partners are on high risk. Virtually all cervical cancers are associated with human papilloma viruses (HPV). This study was conducted to understand the levels of knowledge and attitudes of women towards cervical cancer screening in Al Khan Dubai.It assessed the knowledge and attitudes of women about cervical cancer prevention. 70% of the sexually active women really need to go for cancer screening. It shows that 66% of women in al khan are being affected due to lifestyle and it is affecting women’s decision in relation to cervical cancer screening. To improve cervical cancer screening in al khan area, women should be given more information, motivation, awareness, and sensitization, in order to encourage them to go for a cervical cancer screening. Keywords: Cervix, High risk, HPV, Pre-screening methods, Women.

APA, Harvard, Vancouver, ISO, and other styles

7

Dayanand Katke, Rajshree, and Deepti Prasad. "Cervical Cancer Prevention: Current Scenario." Acta Scientific Cancer Biology 4, no. 2 (January 18, 2020): 01–03. http://dx.doi.org/10.31080/ascb.2020.04.cervical-cancer-prevention-current-scenario.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Singh Randhawa, Amritjot. "Metastatic Breast Cancer to the Uterine Cervix Mimicking Cervical Cancer." Indian Journal of Cancer Education and Research 8, no. 1 (June 1, 2020): 49–52. http://dx.doi.org/10.21088/ijcer.2321.9815.8120.8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Ma, Zhifang, Jie Chen, Ting Luan, Chengzhuo Chu, Wangfei Wu, Yichao Zhu, and Yun Gu. "Proteomic analysis of human cervical adenocarcinoma mucus to identify potential protein biomarkers." PeerJ 8 (July 28, 2020): e9527. http://dx.doi.org/10.7717/peerj.9527.

Full text

Abstract:

Background Cervical cancer is the most common gynecological cancer, encompassing cervical squamous cell carcinoma, adenocarcinoma, and other epithelial tumors. There are many diagnostic methods to detect cervical cancers but no precision screening tool for cervical adenocarcinoma at present. Material and methods The cervical mucus from three normal cervices (Ctrl), three endocervical adenocarcinoma (EA), and three cervical adenocarcinoma in situ (AIS) was collected for proteomic analysis. The proteins were screened using liquid chromatography-mass spectrometry analysis (LC-MS). The biological function of the differently expressed proteins were predicted by Gene Ontology (GO). Results A total of 711 proteins were identified, including 237 differently expressed proteins identified in EA/Ctrl comparison, 256 differently expressed proteins identified in AIS/Ctrl comparison, and 242 differently expressed proteins identified in AIS/EA comparison (up-regulate ≥ 1.5 or down-regulate ≤ 0.67). Functional annotation was performed using GO analysis on 1,056 differently expressed proteins to identify those that may impact cervical cancer, such as heme protein myeloperoxidase, which is involved in the immune process, and APOA1, which is associated with lipid metabolism. Conclusion We used proteomic analysis to screen out differently expressed proteins from normal cervical mucus and cervical adenocarcinoma mucus samples. These differently expressed proteins may be potential biomarkers for the diagnosis and treatment of cervical adenocarcinoma but require additional study.

APA, Harvard, Vancouver, ISO, and other styles

10

Boisen, Michelle, and Richard Guido. "Emerging Treatment Options for Cervical Dysplasia and Early Cervical Cancer." Clinical Obstetrics & Gynecology 66, no. 3 (July 25, 2023): 500–515. http://dx.doi.org/10.1097/grf.0000000000000790.

Full text

Abstract:

Discussion of treatment strategies for cervical cancer precursors, review of medical therapies and emerging therapeutics for treatment of cervical cancers, and updates on new approaches to treating early-stage cervical cancers.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Cervical Cancer"

1

Ibrahim, Emad Moussa. "CD44 in cervical cancer." Thesis, University of Sheffield, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.269370.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Thornton, Julia Susan. "Screening for cervical cancer." Thesis, City University London, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.241442.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Nevin, James. "Pregnancy-associated cervical cancer." Thesis, University of Cape Town, 1991. http://hdl.handle.net/11427/26272.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Ratima, Keri, and n/a. "Cervical cancer in Maori women." University of Otago. Dunedin School of Medicine, 1994. http://adt.otago.ac.nz./public/adt-NZDU20070601.112003.

Full text

Abstract:

This thesis is concerned with cervical cancer amongst New Zealand women, particularly Maori women. Maori women have an alarmingly high incidence of cervical cancer, approximately three times higher than non-Maori women. Maori women experience one of the highest rates of cervical cancer in the world. Chapter one, two and three form the introductory section of the thesis, Section A. Chapter one provides an overview of cervical cancer incidence in the world, followed by a more detailed analysis of the occurrence of cervical cancer in New Zealand and a discussion of the aetiological factors of cervical cancer. Cervical screening is discussed in Chapter two. The ethnic differences in incidence and mortality of cervical cancer between Maori and non-Maori and possible reasons for these differences are studied in Chapter three. Section B consists of the original work undertaken. A pilot study (Chapter four) was conducted to trial the methods for the national study (Chapter five). The national study was a retrospective review of the cervical smear histories of Maori women first diagnosed with invasive cervical cancer over a recent two year period in order to investigate why Maori women have not had their disease detected by screening and treated at the intraepithelial stage. Maori women�s knowledge of and attitudes towards cervical screening were obtained in a survey in Ruatoria (Chapter six). Section C concludes with a chapter (Chapter seven) on the conclusions and recommendations based on the material reviewed and the work undertaken.

APA, Harvard, Vancouver, ISO, and other styles

5

Govorukhina, Natalia I. "Biomarker discovery for cervical cancer." [S.l. : Groningen : s.n. ; University Library of Groningen] [Host], 2007. http://irs.ub.rug.nl/ppn/305362089.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Roeder, Geraldine Elizabeth. "Gene therapy for cervical cancer." Thesis, University of Bristol, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.268704.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Li, Xing. "Novel brachytherapy techniques for cervical cancer and prostate cancer." Diss., University of Iowa, 2015. https://ir.uiowa.edu/etd/1682.

Full text

Abstract:

Intensity-modulated brachytherapy techniques, compensator-based intensity modulated brachytherapy (CBT) and interstitial rotating shield brachytherapy (I-RSBT), are two novel conceptual radiation therapies for treating cervical and prostate cancer, respectively. Compared to conventional brachytherapy techniques for treating cervical cancer, CBT can potentially improve the dose conformity to the high-risk clinical target volume (CTV) of the cervix in a less invasive approach. I-RSBT can reduce the dose delivered to the prostate organ at risks (OARs) with the same radiation dose delivered to the prostate CTV. In this work, concepts and prototypes for CBT and I-RSBT were introduced and developed. Preliminary dosimetric measurements were performed for CBT and I-RSBT, respectively. A CBT prototype system was constructed and experimentally validated. A prototype cylindrical compensator with eight octants, each with different thicknesses, was designed. Direct metal laser sintering (DMLS) was used to construct CoCr and Ti compensator prototypes, and a 4-D milling technique was used to construct a Ti compensator prototype. Gafchromic EBT2 films, held by an acrylic quality assurance (QA) phantom, were irradiated to approximately 125 cGy with an electronic brachytherapy (eBT) source for both shielded and unshielded cases. The dose at each point on the films were calculated using a TG-43 calculation model that was modified to account for the presence of a compensator prototype by ray-tracing. With I-RSBT, a multi-pass dose delivery mechanism with prototypes was developed. Dosimetric measurements for a Gd-153 radioisotope was performed to demonstrate that using multiple partially shielded Gd-153 sources for I-RSBT is feasible. A treatment planning model was developed for applying I-RSBT clinically. A custom-built, stainless steel encapsulated 150 mCi Gd-153 capsule with an outer length of 12.8 mm, outer diameter of 2.10 mm, active length of 9.98 mm, and active diameter of 1.53 mm was used. A partially shielded catheter was constructed with a 500 micron platinum shield and a 500 micron aluminum emission window, both with 180° azimuthal coverage. An acrylic phantom was constructed to measure the dose distributions from the shielded catheter in the transverse plane using Gafchromic EBT3 films. Film calibration curves were generated from 50, 70, and 100 kVp x-ray beams with NIST-traceable air kerma values to account for energy variation. In conclusion, CBT, which is a non-invasive alternative to supplementary interstitial brachytherapy, is expected to improve dose conformity to bulky cervical tumors relative to conventional intracavitary brachytherapy. However, at the current stage, it would be time-consuming to construct a patient-specific compensator using DMLS, and the quality assurance of the compensator would be difficult. I-RSBT is a promising approach to reducing radiation dose delivered to prostate OARs. The next step in making Gd-153 based I-RSBT feasible in clinic is developing a Gd-153 source that is small enough such that the source, shield, and catheter all fit within a 16 guage needle, which has a 1.65 mm diameter.

APA, Harvard, Vancouver, ISO, and other styles

8

Gunnell, Anthony S. "Risk factors for cervical cancer development /." Stockholm, 2007. http://diss.kib.ki.se/2007/978-91-7357-437-2/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

張德凱 and Dekai Zhang. "Telomerase activation in human cervical cancer." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1998. http://hub.hku.hk/bib/B31238038.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Ng, Grace. "Genomic investigations of cervical cancer progression." Thesis, University of Cambridge, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.613036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Cervical Cancer"

1

Dunleavey, Ruth. Cervical Cancer. New York: John Wiley & Sons, Ltd., 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

de la Garza-Salazar, Jaime G., Flavia Morales-Vásquez, and Abelardo Meneses-Garcia, eds. Cervical Cancer. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Keppler, Daniel, and Athena W. Lin, eds. Cervical Cancer. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-2013-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Hirschmann, Kris. Cervical cancer. Detroit: Lucent Books, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Hirschmann, Kris. Cervical cancer. Detroit: Lucent Books/Gale, Cengage Learning, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Hirschmann, Kris. Cervical cancer. Detroit: Lucent Books, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Hirschmann, Kris. Cervical cancer. Detroit: Lucent Books/Gale, Cengage Learning, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Hasan, Heather. Cervical cancer. New York: Rosen, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Royal College of Obstetricians and Gynaecologists., ed. Cervical smears: Preventing cervical cancer. London: RCOG, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Austoker, Joan. Cervical cancer screening. [London]: Cancer Research Campaign, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Cervical Cancer"

1

de la Garza-Salazar, Jaime G., Abelardo Meneses-García, Oscar Arrieta-Rodríguez, José Luis Aguilar-Ponce, and Paula Juarez-Sánchez. "Introduction." In Cervical Cancer, 1–17. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

González-Enciso, Aarón, Salim Abraham Barquet-Muñoz, and Milagros Pérez-Quintanilla. "Primary Surgical Treatment of Cervical Cancer." In Cervical Cancer, 151–62. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Montalvo-Esquivel, Gonzalo, Milagros C. Pérez-Quintanilla, Angel Herrera-Gómez, Francisco Javier Alcalá-Prieto, Flavia Morales-Vásquez, and Horacio Noé López Basave. "Surgical Treatment for Advanced or Recurrent Disease in Cervical Cancer." In Cervical Cancer, 163–76. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Mota-García, Aida, Monika Blake-Cerda, Bonifacio Ramón-Ortega, Roque Alberto Guadarrama-Fleites, and Guadalupe Elizabeth Trejo-Durán. "Radiotherapy in Cervical Cancer." In Cervical Cancer, 177–97. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Morales-Vásquez, Flavia, Claudia Cano-Blanco, Jaime Alberto Coronel-Martínez, Lucely Cetina-Pérez, Jorge Martínez-Tlahuel, Julio César Velasco-Rodríguez, Horacio N. López-Basave, and Jaime G. de la Garza-Salazar. "Systemic Treatment of Cervical Cancer." In Cervical Cancer, 199–214. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Marquez-Manriquez, Juan P., Erik Ramos, and Dolores Gallardo-Rincón. "Immuno-Oncology in Cervical Cancer." In Cervical Cancer, 215–23. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Allende-Pérez, Silvia, Emma Verástegui-Avilés, Dana A. Pérez-Camargo, Georgina Domínguez-Ocadio, and Frank D. Ferris. "Palliative Care in Cervical Cancer Patients." In Cervical Cancer, 225–52. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Morales-Vásquez, Flavia, Claudia Cano-Blanco, Jaime Alberto Coronel-Martínez, Lucely Cetina-Pérez, Julio César Velasco-Rodríguez, Horacio N. López-Basave, and Jaime G. de la Garza-Salazar. "Special Conditions and Follow-Up in Cervical Cancer." In Cervical Cancer, 253–68. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Reynoso-Noverón, Nancy, Adriana Peña-Nieves, Maryori Ortiz Rodríguez, and Alejandro Mohar-Betancourt. "Cervical Cancer Epidemiology." In Cervical Cancer, 19–33. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Astudillo-de la Vega, H., E. Ruiz-Garcia, C. Lopez-Camarillo, Jaime G. de la Garza-Salazar, A. Meneses-Garcia, and L. Benitez-Bribiesca. "Malignant Transforming Mechanisms of Human Papillomavirus." In Cervical Cancer, 35–56. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Cervical Cancer"

1

Thangamani, R., M. Vimaladevi, S. H. Varshini, A. Mohammed Aadhil, and K. R. Sasvath. "Cervical Cancer Prediction using Machine Learning." In 2024 15th International Conference on Computing Communication and Networking Technologies (ICCCNT), 1–7. IEEE, 2024. http://dx.doi.org/10.1109/icccnt61001.2024.10725056.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Vemanamandhi, Priyanka. "A Rare mimicker of Cervical Cancer- Cervical Amebiasis." In 10th National Conference of Asia Oceania Research Organisation on Genital Infections and Neoplasia, India. AOGIN 2021, 2021. http://dx.doi.org/10.7869/aogin68.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

"Aspirin and Cervical Cancer." In 2016 International Conference on Biological and Environmental Science. Universal Researchers, 2016. http://dx.doi.org/10.17758/ur.u0616230.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Bran, Liliana. "CERVICAL CANCER CLUSTERING IN ARAD AND CERVICAL CANCER SCREENING PROGRAMMES IN ROMANIA." In 5th SGEM International Multidisciplinary Scientific Conferences on SOCIAL SCIENCES and ARTS SGEM2018. STEF92 Technology, 2018. http://dx.doi.org/10.5593/sgemsocial2018h/31/s13.074.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Ramesh, Hariharan, Abdulla Al Serkal, Houssein Kanso, Noora Aljallaf, and Jinane Mounsef. "Cerviscan: Advancing Cervical Cancer Detection through Deep Learning Innovations." In 2024 IEEE 37th International Symposium on Computer-Based Medical Systems (CBMS). IEEE, 2024. http://dx.doi.org/10.1109/cbms61543.2024.00064.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Srivastava, Astha, Bindiya Gupta, Vikas Lakha, and Shilpa Singh. "Study on cervical cancer screening amongst nurses." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685284.

Full text

Abstract:

Objective: To study the knowledge, attitude and practice of nurses at tertiary centre regarding cervical cancer screening. Material and Methods: Validated questionnaire was circulated amongst staff nurses at tertiary care centre after taking informed consent. Results and Discussion: Cancer of cervix is the most common genital tract malignancy in female and it is ranked second to breast cancer. It has a positive association with HPV infection. Cervical cancer incidence and mortality have declined substantially following introduction of screening programmes. This present study investigated the knowledge, attitude and practice of nurses at GTB Hospital towards cervical cancer risk factors, sign & symptoms and screening as they are important health professionals. In our study, the results showed that 99% of respondents were aware of Pap smear as screening programme and about 60-70% were aware of HPV as positive organism, but most of them never had a Pap smear done before. Majority of them did not know VIA, VILI and colposcopy as screening techniques. Conclusion: It may thus be recommended that institutions should periodically organize seminars and training for health personnel especially the nurses which form a group of professionals that should give health education to women about cervical cancer.

APA, Harvard, Vancouver, ISO, and other styles

7

Ali, Mohd, Mehboob Ali, and Mohd Javed. "DCGAN for Synthetic Data Augmentation of Cervical Cancer for Improved Cervical Cancer Classification." In 2024 IEEE International Students' Conference on Electrical, Electronics and Computer Science (SCEECS). IEEE, 2024. http://dx.doi.org/10.1109/sceecs61402.2024.10482312.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Amengual, J., A. Torrent, AM Quintero Duarte, and M. Ruiz. "385 Undiagnosed invasive cervical cancer." In ESGO 2021 Congress. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/ijgc-2021-esgo.27.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Jiamset, Ingporn, Kulisara Nanthamongkolkul, and Rakchai Buhachat. "Ovarian transposition and cervical cancer." In The 7th Biennial Meeting of Asian Society of Gynecologic Oncology. Korea: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology, 2021. http://dx.doi.org/10.3802/jgo.2021.32.s1.c27.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Wajih, Oumaima, Bouab Maryam, Oumnia Hlaibi, Mohammad Jalal, Amine Lamrissi, and Said Bouhya. "805 Cervical cancer and pregnancy." In ESGO 2024 Congress Abstracts. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/ijgc-2024-esgo.203.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Cervical Cancer"

1

Ciapponi, Agustín. What is the effectiveness of interventions targeted at women to improve the uptake of cervical cancer screening? SUPPORT, 2016. http://dx.doi.org/10.30846/1611112.

Full text

Abstract:

World-wide, cervical cancer is the second most common cancer in women and more than 85% of women dying from cervical cancer live in the developing world. Increasing the uptake of screening, alongside increasing informed choice, is key to controlling this disease through prevention and early detection. Methods of encouraging women to undergo cervical screening include invitations to screening; reminders to attend screening; education to increase knowledge of screening programmes or of cervical cancer; message framing (positive or negative messages about screening); counselling regarding barriers to screening; risk factor assessment of individuals; procedures, such as making the screening process easier; and economic interventions, such as incentives to attend screening.

APA, Harvard, Vancouver, ISO, and other styles

2

Wilbur, David C., Barbara A. Crothers, John H. Eichhorn, Min S. Ro, and Jeffrey A. Gelfand. Internet-Based Cervical Cancer Screening Program. Fort Belvoir, VA: Defense Technical Information Center, May 2008. http://dx.doi.org/10.21236/ada486866.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Callaghan, Timothy H., Alva O. Ferdinand, Samuel D. Towne Jr, Marvellous Akinlotan, Kristin Primm, and Jane Bolin. Cancer Mortality in Rural America. College Station, TX: Southwest Rural Health Research Center, Texas A&M School of Public Health, November 2018. http://dx.doi.org/10.21423/1969.1/201263.

Full text

Abstract:

For scholars and policymakers alike, understanding the burden of cancer on society is a critical topic for investigation. Cancer consistently ranks as the second leading cause of death in the U.S., and cancers of the prostate, breast, lung, and colorectal areas are particularly problematic. This policy brief works to understand the scope of cancer mortality in urban and rural areas of the U.S. and across census regions. It finds that age-adjusted mortality rates are higher for lung, prostate, and colon cancer in rural areas than in urban areas but also that mortality rates are lower for breast and cervical cancers in rural areas than in urban areas. In addition, this brief identifies important discrepancies in cancer mortality across regions, with lower rates in the West for all analyzed cancer types except prostate cancer, and higher rates for most cancers in the rural South.

APA, Harvard, Vancouver, ISO, and other styles

4

Saville, Marion. Can the Indo-Pacific eliminate cervical cancer? Edited by Suzannah Lyons. Monash University, February 2024. http://dx.doi.org/10.54377/a7c6-8e0d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Yelena, Gorina, and Elgaddal Nazik. Patterns of Mammography, Pap Smear, and Colorectal Cancer Screening Services Among Women Aged 45 and Over. National Center for Health Statistics, June 2021. http://dx.doi.org/10.15620/cdc:105533.

Full text

Abstract:

This study examines and compares sociodemographic, health status, and health behavior patterns of screening for breast cancer, cervical cancer, and colorectal cancer among women aged 45 and over in the United States.

APA, Harvard, Vancouver, ISO, and other styles

6

Zou, Yihua, Fangqin Tong, Meng Guan, Chun Bi, and Xia Wang. Efficacy and safety of Anti-angiogenesis combined with chemoradiotherapy in the treatment of locally advanced cervical cancer: A Meta-Analysis of Randomized Controlled Trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2022. http://dx.doi.org/10.37766/inplasy2022.7.0077.

Full text

Abstract:

Review question / Objective: To Systematicly evaluate of the clinical efficacy and safety of the combination of anti-angiogenesis and simultaneous radiotherapy in the treatment of cervical cancer. Condition being studied: Locally advanced cervical cancer. We searched databases including PubMed, Cochrane Library, Embase, Web of Science CNKI, Wanfang, VIP and CBM, and the International Clinical Trial Registry Platform (ICTRP) and the Chinese Clinical Registry(ChiCTR) to collect the clinical studies about the randomized controlled trial (RCTS) of anti-angiogenic drugs (mainly Endu, apatinib and bevacizumab) combined with chemoradiotherapy in the treatment of cervical cancer. The time limit is from the establishment of the database to April 2022. RevMan 5.4 software was used to analyze the short-term efficacy and the incidence of adverse reactions.

APA, Harvard, Vancouver, ISO, and other styles

7

Avitabile, Ciro. Spillover Effects in Healthcare Programs: Evidence on Social Norms and Information Sharing. Inter-American Development Bank, December 2012. http://dx.doi.org/10.18235/0011439.

Full text

Abstract:

Although cervical cancer is considered one of the most preventable types of cancer, mortality rates in many developing countries are extremely high. This paper exploits the randomized research design of a large welfare program "PROGRESA" to study the existence of spillover effects in cervical cancer screening in rural Mexico. I find significant evidence of increased demand for Papanicolaou cervical cancer screening among women ineligible for the transfer, yet no evidence of similar externalities in non-gender specific tests, such as blood pressure and blood sugar checks. Different pieces of evidence from the evaluation sample and the nationwide rollout are consistent with the hypothesis that the PROGRESA program has weakened the social norm related to husbands' opposition to screening of their wives by male doctors. I find less evidence to support the hypothesis that the spillover effect is driven by higher levels of health information.

APA, Harvard, Vancouver, ISO, and other styles

8

Vo, Tuong, Nada Salloukh, Tatiana Swanson, Xiao Zhu, and Laura Reed. Evidenced-Based Strategies to Increase Cervical Cancer Screening Rates. University of Tennessee Health Science Center, April 2024. http://dx.doi.org/10.21007/con.dnp.2024.0080.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Hoeijmakers, Yvonne M. Cervical biopsy after chemoradiation for locally advanced cervical cancer to identify residual disease: a retrospective cohort study. Science Repository OÜ, March 2019. http://dx.doi.org/10.31487/j.jso.2019.01.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Guo, Ying, Linlin Ma, and Qiwei Li. Laparoscopic nerve sparing radical hysterectomy for the treatment of cervical cancer. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2021. http://dx.doi.org/10.37766/inplasy2021.9.0047.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!